This paper describes work to improve the targeting of drug delivery for such infections by modifying intranasal spray usage protocols. Computational fluid dynamic studies and experimental validation work show that with an improved protocol, involving more shallowed (almost horizontal) angling of the intranasal spray, drug delivery to the nasopharyngeal viral infection ‘hot spot’ can be doubled. The optimal droplet size for drug delivery for such applications is discussed, and the robustness of the developed protocol is highlighted, with respect to the consistency of drug delivery.
Learn more about Aptar Pharma Expertise
in Nasal Drug Delivery
This Might Also Be of Interest
Nasal Drug Development, Trends and Challenges with Nasal Formulations
Publications, Pharmaceutical, Device Innovations, Brand Differentiation, Market Insights, Product Solutions
Nose to Brain Drug Delivery – A Promising Future
Webinars, Pharmaceutical, Product Solutions, Device Innovations, Brand Differentiation, Market Insights
Aptar Pharma Q&A on trends and challenges in nasal drug delivery
Publications, Pharmaceutical, Brand Differentiation, Market Insights, Product Solutions, Device Innovations
Why it is time to think differently about Nasal delivery of Biologics
Publications, Pharmaceutical, Innovation & Insights, Brand Differentiation, Market Insights, Product Solutions
